Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Selective Inhibitors of Human Neuraminidase 3.

Guo T, Dätwyler P, Demina E, Richards MR, Ge P, Zou C, Zheng R, Fougerat A, Pshezhetsky AV, Ernst B, Cairo CW.

J Med Chem. 2018 Mar 8;61(5):1990-2008. doi: 10.1021/acs.jmedchem.7b01574. Epub 2018 Feb 21.

PMID:
29425031
2.

Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.

Zhang Y, Albohy A, Zou Y, Smutova V, Pshezhetsky AV, Cairo CW.

J Med Chem. 2013 Apr 11;56(7):2948-58. doi: 10.1021/jm301892f. Epub 2013 Mar 26.

PMID:
23530623
3.

The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.

Hyun SW, Liu A, Liu Z, Cross AS, Verceles AC, Magesh S, Kommagalla Y, Kona C, Ando H, Luzina IG, Atamas SP, Piepenbrink KH, Sundberg EJ, Guang W, Ishida H, Lillehoj EP, Goldblum SE.

Glycobiology. 2016 Aug;26(8):834-49. doi: 10.1093/glycob/cww060. Epub 2016 May 25.

4.

Selective Inhibitors of Human Neuraminidase 1 (NEU1).

Guo T, Héon-Roberts R, Zou C, Zheng R, Pshezhetsky AV, Cairo CW.

J Med Chem. 2018 Dec 27;61(24):11261-11279. doi: 10.1021/acs.jmedchem.8b01411. Epub 2018 Dec 5.

PMID:
30457869
5.

Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.

Zou Y, Albohy A, Sandbhor M, Cairo CW.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7529-33. doi: 10.1016/j.bmcl.2010.09.111. Epub 2010 Sep 29.

PMID:
21036040
6.

Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.

Richards MR, Guo T, Hunter CD, Cairo CW.

Bioorg Med Chem. 2018 Oct 15;26(19):5349-5358. doi: 10.1016/j.bmc.2018.05.035. Epub 2018 May 23.

PMID:
29903413
7.

Potent Inhibitors against Newcastle Disease Virus Hemagglutinin-Neuraminidase.

Rota P, La Rocca P, Piccoli M, Montefiori M, Cirillo F, Olsen L, Orioli M, Allevi P, Anastasia L.

ChemMedChem. 2018 Feb 6;13(3):236-240. doi: 10.1002/cmdc.201700755. Epub 2018 Jan 9.

PMID:
29231283
8.

Analysis of inhibitor binding in influenza virus neuraminidase.

Smith BJ, Colman PM, Von Itzstein M, Danylec B, Varghese JN.

Protein Sci. 2001 Apr;10(4):689-96.

9.

Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.

Albohy A, Zhang Y, Smutova V, Pshezhetsky AV, Cairo CW.

ACS Med Chem Lett. 2013 May 7;4(6):532-7. doi: 10.1021/ml400080t. eCollection 2013 Jun 13.

10.

Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.

Tindal DJ, Dyason JC, Thomson RJ, Suzuki T, Ueyama H, Kuwahara Y, Maki N, Suzuki Y, von Itzstein M.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1655-8. Epub 2007 Jan 8.

PMID:
17236768
11.
12.
13.

2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.

Ikeda K, Sato K, Nishino R, Aoyama S, Suzuki T, Sato M.

Bioorg Med Chem. 2008 Jul 15;16(14):6783-8. doi: 10.1016/j.bmc.2008.05.055. Epub 2008 Jun 12.

PMID:
18555688
14.

Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.

Nishino R, Ikeda K, Hayakawa T, Takahashi T, Suzuki T, Sato M.

Bioorg Med Chem. 2011 Apr 1;19(7):2418-27. doi: 10.1016/j.bmc.2011.02.010. Epub 2011 Feb 18.

PMID:
21382718
15.

Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor.

Lima AH, Souza PR, Alencar N, Lameira J, Govender T, Kruger HG, Maguire GE, Alves CN.

Chem Biol Drug Des. 2012 Jul;80(1):114-20. doi: 10.1111/j.1747-0285.2012.01380.x. Epub 2012 Apr 13.

PMID:
22416952
16.

Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.

Khedri Z, Li Y, Cao H, Qu J, Yu H, Muthana MM, Chen X.

Org Biomol Chem. 2012 Aug 14;10(30):6112-20. doi: 10.1039/c2ob25335f. Epub 2012 May 29.

PMID:
22641268
17.

The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.

Levin Perlman S, Jordan M, Brossmer R, Greengard O, Moscona A.

Virology. 1999 Dec 5;265(1):57-65.

18.
19.

Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).

Magesh S, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.

Bioorg Med Chem Lett. 2008 Jan 15;18(2):532-7. Epub 2007 Nov 28.

PMID:
18068975
20.

A facile synthesis of 2-deoxy-2,3-didehydroneuraminic acid derivatives.

Ikeda K, Konishi K, Sano K, Tanaka K.

Chem Pharm Bull (Tokyo). 2000 Jan;48(1):163-5.

PMID:
10705498

Supplemental Content

Support Center